Advertisement

Der Urologe

, Volume 51, Issue 5, pp 684–686 | Cite as

Retroperitoneale Lymphadenektomie – pro laparoskopisch

  • L. Lusuardi
  • G. Janetschek
Leitthema

Zusammenfassung

Die funktionellen sowie die onkologischen Ergebnisse der laparoskopischen retroperitonealen Lymphadenektomie (L-RPLND) sind auch im 5-Jahres-Follow-up mit der offenen retroperitonealen Lymphadenektomie (O-RPLND) vergleichbar. In den letzten veröffentlichen Serien von „High-volume-Laparoskopiezentren“ zeigte sich zusätzlich eine Tendenz zur geringeren Komplikationsrate im Vergleich zur O-RPLND. In der Reihe der robotisch assistierten retroperitonealen Lymphadenektomie (R-RPLND) gibt es bis dato nur 2 Fallberichte sodass kein klarer Nutzen für das robotisch laparoskopisch assistierte Verfahren gefunden werden konnte.

Schlüsselwörter

Lymphadenektomie, retroperitoneale Hodenkarzinom Laparoscopie da Vinci®-System Lymphadenektomie, assistierte 

Retroperitoneal lymphadenectomy – pro laparoscopy

Abstract

The functional and oncological results of laparoscopic retroperitoneal lymphadenectomy (L-RPLND) have proven to be as efficacious as open series (O-RPLND) after 5 year follow-up. In the most recent publication series from high-volume laparoscopy centres, there was a trend towards fewer complications in L-RPLND compared to O-RPLND. Up to now only two case series of four treated patients have been reported adopting a robotic-assisted retroperitoneal lymphadenectomy for testicular cancer so that it is not yet possible to judge whether it is useful tool or not.

Keywords

Lymphadenectomy, retroperitoneal Testicular cancer Laparoscopy da Vinci® system Assisted laparoscopy 

Notes

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seinen Koautor an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Stephenson AJ, Bosl GJ, Motzer RJ et al (2005) Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome. J Clin Oncol 23:2781–2788PubMedCrossRefGoogle Scholar
  2. 2.
    Rabbani F, Sheinfeld J, Farivar-Mohseni H et al (2001) Low volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol 19:2020–2025PubMedGoogle Scholar
  3. 3.
    Krege S, Beyer J, Souchon R et al (2008) European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 53:478–496PubMedCrossRefGoogle Scholar
  4. 4.
    Hulbert JC, Fraley EE (1992) Laparoscopic retroperitnoeal lymphadenectomy: new approach to pathologic staging of clinical stage I germ cell tumors of the testis. J Endourol 6:123–125CrossRefGoogle Scholar
  5. 5.
    Rassweiler JJ, Scheitlin W, Heidenreich A et al (2008) Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminmoatous testis cancer? A European Perspective. Eur Urol 54:1004–1019PubMedCrossRefGoogle Scholar
  6. 6.
    Weissbach L, Boedefeld EA, Horstmann-Dubral B (1990) Surgical treatment of stage-I non seminomatous germ cell testis tumor. Final results of a prospective multicenter trial 1982-1987. Testicular Tumor Study Group. Eur Urol 17:97–106PubMedGoogle Scholar
  7. 7.
    Donohue JP, Foster RS (1998) Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve sparing techniques. Urol Clin North Am 25:461–468PubMedCrossRefGoogle Scholar
  8. 8.
    Lima GC, Kohanim S, Rais-Bahrami S (2005) Laparoscopic retroperitoneal lymph node dissection after prior open retroperitoneal lymphadenectomy and chemotherapy. Urology 66:1319Google Scholar
  9. 9.
    Escalera AC, Chiva RV, Pascual MC (2006) Post chemotherapy laparoscopic retroperitoneal lymph node dissection. Arch Esp Urol 59:517–523Google Scholar
  10. 10.
    Calestroupat JP, Sanchez-Salas R, Cathelineau X (2009) Postchemotherapy laparoscopic retroperitoneal lymph node dissection in nonseminomatous germ-cell tumor. J Endourol 23:645–650PubMedCrossRefGoogle Scholar
  11. 11.
    Davol P, Sumfest J, Rukstalis D (2006) Robotic-assisted laparoscopic retroperitoneal lymph node dissection. Urology 67:199PubMedCrossRefGoogle Scholar
  12. 12.
    Williams SB, Lau CS, Josephson DY (2011) Initial series of robot-assisted laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer. Eur Urol 60:1299–1302PubMedCrossRefGoogle Scholar
  13. 13.
    Eggener SE, Carver BS, Sharp DS (2007) Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer. J Urol 177:937–942PubMedCrossRefGoogle Scholar
  14. 14.
    Allaf ME, Bhayani SB, Link RE (2005) Laparoscopic retroperitoneal lymph node dissection: duplication of open technique. Urology 65:575–577PubMedCrossRefGoogle Scholar
  15. 15.
    Jewett MA, Kong YS, Goldberg SD (1998) Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol 139:1220–1224Google Scholar
  16. 16.
    Al-Tourah AJ, Murray N, Coppin C et al (2005) Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia. J Urol 174:2209–2213PubMedCrossRefGoogle Scholar
  17. 17.
    Colleselli K, Poisel S, Schachtner W et al (1990) Nerve-preserving bilateral retroperitoneal lymphadenectomy: anatomical study and operative approach. J Urol 144:293–298PubMedGoogle Scholar
  18. 18.
    Heidenreich A, Albers P, Hartmann M et al (2003) Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol 169:1710–1714PubMedCrossRefGoogle Scholar
  19. 19.
    Steiner H, Zangerl F, Stöhr B (2008) Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer. J Urol 180:1348–1352PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  1. 1.Abteilung für Urologie und AndrologieParacelsus Medizinische UniversitätSalzburgÖsterreich

Personalised recommendations